DGAP-News: Celesio AG / Key word(s): Miscellaneous
Celesio AG: Celesio sells Pharmexx to Ireland-based United Drug
26.07.2012 / 08:00
---------------------------------------------------------------------
Celesio sells Pharmexx to Ireland-based United Drug
* Celesio focusing on core business
* United Drug will drive international development of Pharmexx business
Stuttgart, Germany / Dublin, Ireland, 26 July 2012. Celesio sells its
subsidiary Pharmexx to United Drug, a leading international provider of
services to healthcare manufacturers and pharmaceutical retailers. United
Drug acquires the Celesio subsidiary Pharmexx, which specialises in
marketing and personnel services for pharmaceutical companies, for 35
million euro. The deal is expected to be closed by the 31 August 2012
following receipt of the necessary regulatory clearances.
Celesio CEO Markus Pinger: 'Following quickly after the quite recently
announced Movianto transaction, the sale of Pharmexx is again a successful
move towards Celesio being positioned to focus on its core business. We can
now concentrate our resources and efforts to foster the growth of our core
business. With United Drug, we have found an investor who will leverage
Pharmexx's international potential and further develop the company. This is
also in the best interest of the Pharmexx employees, a fact that has always
been a crucial factor for us in the sales process.'
United Drug's Chief Executive, Liam FitzGerald said: 'The acquisition is a
major step forward in our ambition to become the leading global provider of
contract sales outsourcing services to the pharmaceutical industry. It is
also another significant milestone in the development of United Drug into a
truly international provider of outsourced services to healthcare
manufacturers.'
The sale of marketing and sales services provider Pharmexx, which has been
part of the Celesio Group since 2006, was decided in context with a
fundamental strategic realignment. In October 2011, Celesio had announced
that it would now focus more consistently on its core business, i.e.
pharmaceutical wholesale and pharmacies, which stand for more than 95 per
cent of the group business.
Press contact
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
media@celesio.com
About Celesio Group
Celesio is a leading international trade, logistics and service company
working in the pharmaceutical and healthcare sector that proactively and
preventatively ensures that patients receive optimum care and support. We
operate in 27 countries worldwide and employ around 46,000 people. With
more than 2,200 of our own and 4,500 partner and brand partner pharmacies,
we look after more than two million customers daily. We supply around
65,000 pharmacies and hospitals with up to 130,000 medications through our
approximately 140 branches.
About Pharmexx
Pharmexx is a leading international outsourcing solutions provider for
sales & marketing to the Pharma and Medtech Industry, with a presence in 18
markets in Europe, Canada and Latin America and the expertise of 2,300
healthcare professionals. All top 25 global leading pharmaceutical
companies belong to Pharmexx' more than 250 customers worldwide. Pharmexx
provides Contract Sales Force and Vacancy Management Solutions,
patient-centric Health Management Services to improve treatment adherence,
Brand Management and innovative and integrated e-Marketing and Call Center
Solutions for prescribers, pharmacists and patients. www.pharmexx.com
About United Drug plc
Listed on the Stock Exchanges in London and Dublin, United Drug is a
leading international provider of services to healthcare manufacturers and
pharmaceutical retailers, with operations in the UK, Ireland, the
Netherlands, Belgium, and the USA. The Company operates across three
divisions, Healthcare Supply Chain, Sales, Marketing & Medical, and
Packaging & Specialty.
End of Corporate News
---------------------------------------------------------------------
26.07.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-736
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
179193 26.07.2012
DGAP-News: Celesio AG: Celesio sells Pharmexx to Ireland-based United Drug
| Source: EQS Group AG